Skip to main content
. 2010 May-Jun;2(3):256–265. doi: 10.4161/mabs.2.3.11641

Figure 4.

Figure 4

Reduction and exacerbation of in vitro immunogenicity by epitope amino acid sequence modifications. All proliferative responses rates to epitope variants were standardized to the unmodified parent epitope peptide response. (A) Distribution of standardized response rates of the variant peptides. (B) Distribution of standardized average stimulation index of the variant peptides.